# Rallybio Corp: insider transactions

RLYB · Nasdaq · CIK 1739410 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rlyb.md) · [Financials](/companies/rlyb/financials.md) · [Filings](/companies/rlyb/filings.md) · [Insiders](/companies/rlyb/insiders.md)

## All transactions: 4

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-27 | [Uden Stephen](/insiders/1332141.md) | Chief Executive Officer, Director, Officer | Option exercise (M) | 33,244 | $6.08 | $202.1k | [Form 4](/filings/0001193125-26-438086.md) |
| 2026-10-27 | [Lieber Jonathan I](/insiders/1350090.md) | Chief Financial Officer, Officer | Sale (S) | 599 | $16.04 | $9.6k | [Form 4](/filings/0001193125-26-436314.md) |
| 2026-10-26 | [Chung Wendy](/insiders/1922605.md) | Director | Option exercise (M) | 2,062 | $15.28 | $31.5k | [Form 4](/filings/0001193125-26-436313.md) |
| 2026-10-26 | [Lieber Jonathan I](/insiders/1350090.md) | Chief Financial Officer, Officer | Grant or award (A) | 2,500 | $0.00 | $0 | [Form 4](/filings/0001193125-26-436314.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 18:07 ET. No prices; not investment advice.